InvestorsHub Logo
Followers 43
Posts 5486
Boards Moderated 0
Alias Born 11/15/2013

Re: Chemdeps post# 98755

Wednesday, 04/22/2015 11:41:19 AM

Wednesday, April 22, 2015 11:41:19 AM

Post# of 403225
Go back to what Leo reported in Jan20 PR, Ovarian Cancer Response -- Potential Major Breakthrough in Oncology. "[bThe Principal Investigators for the Kevetrin trial have requested that the Company start preparing a presentation to be used for an article on the safety and pharmacological effect of Kevetrin on multiple cancer lines as demonstrated in the clinical trial. I believe first uplist then the article is released showing pharmacological effect of Kevetrin. Then ASCO where Dr. Geoffrey Shapiro does the presentation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News